This is the authors' abstract. We don't add key points for this paper.
Cutaneous T-cell lymphomas are characterized by heterogeneity of clinical variants, further complicated by genomic and microenvironmental variables. Furthermore, in vitro experiments are hampered by the low culture efficiency of these malignant cells. Animal models are essential for understanding the pathogenetic mechanisms underlying malignancy and for discovering new anticancer treatments. They are divided into two main categories: those in which tumors arise in the host owing to genetic modifications and those that use tumor cell transplantation. In this review, we summarize the attempts to decipher the complexity of the pathogenesis of cutaneous T-cell lymphoma by exploiting genetically modified and xenograft models.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Bresin et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: